N-methyl-N-(6-methyl-2-((4aS,5aR)-5a-methyl-1,4,4a,5,5a,6-hexahydrocyclopropa[f]indazol-3-yl)-1H-benzo[d]imidazol-5-yl)-2-(3-oxomorpholino)acetamide

ID: ALA5086824

PubChem CID: 156495003

Max Phase: Preclinical

Molecular Formula: C24H28N6O3

Molecular Weight: 448.53

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cc2[nH]c(-c3n[nH]c4c3C[C@@H]3C[C@]3(C)C4)nc2cc1N(C)C(=O)CN1CCOCC1=O

Standard InChI:  InChI=1S/C24H28N6O3/c1-13-6-16-17(8-19(13)29(3)20(31)11-30-4-5-33-12-21(30)32)26-23(25-16)22-15-7-14-9-24(14,2)10-18(15)27-28-22/h6,8,14H,4-5,7,9-12H2,1-3H3,(H,25,26)(H,27,28)/t14-,24-/m1/s1

Standard InChI Key:  PUEGWEOKQAPJCD-JBEBIEQOSA-N

Molfile:  

 
     RDKit          2D

 34 39  0  0  0  0  0  0  0  0999 V2000
    1.0414  -15.2488    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0414  -16.0745    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7546  -16.4811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4678  -16.0745    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4678  -15.2488    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7546  -14.8297    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1848  -14.8359    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8992  -15.2529    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6160  -14.8401    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8967  -16.0786    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.3305  -15.2571    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6184  -14.0143    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3267  -16.0838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0403  -16.4966    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0437  -14.8446    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7538  -15.2579    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7550  -16.0845    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5418  -16.3375    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.0283  -15.6672    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5397  -14.9985    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.6094  -16.4918    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8537  -15.6613    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1257  -15.2485    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.3397  -14.9918    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.1269  -16.0743    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3430  -16.3270    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1689  -17.1283    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7366  -16.6187    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5636  -17.4258    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7847  -17.6838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3960  -18.2277    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3692  -18.3939    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   11.2737  -17.8380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7546  -14.0081    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  2  0
  9 11  1  0
  9 12  1  0
 11 13  2  0
 13 14  1  0
 14 17  2  0
 16 15  2  0
 15 11  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 16  1  0
 13 21  1  0
 22 26  1  0
 25 23  1  0
 23 24  1  0
 24 22  2  0
 19 22  1  0
 25 26  2  0
 25 28  1  0
 26 27  1  0
 27 30  1  0
 29 28  1  0
 30 29  1  0
 31 30  1  0
 29 31  1  0
 30 32  1  6
 29 33  1  6
  6 34  2  0
M  END

Alternative Forms

  1. Parent:

    ALA5086824

    ---

Associated Targets(Human)

ITK Tclin Tyrosine-protein kinase ITK/TSK (3699 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
IL2 Tchem Interleukin-2 (144 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NTRK1 Tclin Nerve growth factor receptor Trk-A (7922 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 448.53Molecular Weight (Monoisotopic): 448.2223AlogP: 2.21#Rotatable Bonds: 4
Polar Surface Area: 107.21Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 10.44CX Basic pKa: 4.18CX LogP: 1.54CX LogD: 1.54
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.64Np Likeness Score: -1.00

References

1. Abdel-Magid AF..  (2021)  Dual Inhibition of IL-2-Inducible T-Cell Kinase (ITK) and Tropomyosin Receptor Kinase A (TRKA) as Potential Treatment for Atopic Dermatitis and Other Inflammatory and Autoimmune Diseases.,  12  (12.0): [PMID:34917248] [10.1021/acsmedchemlett.1c00619]

Source